7 new cases of COVID-19; 6 of them identified in quarantine

856

Seven (7) new cases of COVID-19 were identified out of 647 tests performed by DPHSS on Sunday, April 4, and tests from additional labs from Friday, April 2 to Sunday, April 4. Six (6) cases reported recent travel history and were identified in quarantine.

To date, there have been a total of 7,823 officially reported cases of COVID-19 with 136 deaths, 31 cases in active isolation, and 7,656 not in active isolation.

TODAY’S CAR SCORE

0.2

The COVID Area Risk (CAR) Score accounts for the incidence of new cases, how well current testing identifies these cases, and the rate of spread. The ideal long-term goal is to sustain a CAR Score of 2.5 or less, which has been shown to correlate with very low to zero COVID-related hospitalizations and deaths.

The following provides COVID-19 test results from additional labs for Friday, April 2 to Sunday, April 4:

COVID-19 CASE COUNT

TOTAL

NEW CASES REPORTED TODAY

PAST 7 DAYS

COVID-19 CASES:

7,823

7

19

CONFIRMED CASES:

7,613

7

19

PROBABLE CASES:

210

0

0

 

COVID-19 TESTING

ON GUAM

TOTAL

NEW TESTS

REPORTED TODAY

7-DAY

% POSITIVE

DIAGNOSTIC TESTS

142,690

647

1.1%

MOLECULAR TESTS

132,425

629

1.1%

ANTIGEN TEST

10,265

18

0%

SEROLOGY TESTS

367

1

0%

 

CASE BREAKDOWN

STATUS

TOTAL

CURRENT ISOLATION LOCATION

TOTAL

COVID-19 Death

136

Hospital

0

Active Isolation

31

Home

13

Not In Isolation

7,656

Isolation Facility

7

Civilian

7,413

Military

11

Military Service Member

410

 

COVID HOSPITAL CENSUS

Guam Memorial Hospital

Guam Regional Medical City

U.S. Naval Hospital

TOTAL

COVID ADMISSION

0

0

0

0

IN ICU

0

0

0

0

ON VENTILATOR

0

0

0

0

 

Preliminary COVID-19 vaccinations administered from December 17 to April 4:

Vaccine Maker

1st Doses Administered

2nd Doses Administered

Fully Immunized

Pfizer-BioNTech

36,399

16,761*

16,761

Moderna

19,744**

15,296***

15,296

Johnson & Johnson Janssen

149****

TOTALS:

56,143

32,057

32,206

*Administering second doses of Pfizer-BioNTech COVID-19 vaccinations began on January 4, 2021.

**Administering first doses of Moderna COVID-19 vaccinations began on January 8, 2021.

***Administering second doses of Moderna COVID-19 vaccinations began on January 29, 2021.

****Johnson &Johnson/Janssen COVID-19 vaccinations began on March 15 and were developed as a one-dose series.

 

Total Doses Administered

Total Doses Allotted

% Administered

Doses Remaining

88,349^

129,900^^

68.01%

41,551

^As of April 4, 2021. Total doses administered and allotted doses differ as vaccinators were able to draw additional doses per vial. Additionally, the U.S. Food and Drug Administration’s February 25, 2021 revision of their Fact Sheet relative to the Pfizer-BioNTech Emergency Use Authorization now states, “After dilution, one vial contains six doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains five doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons.” | ^^Reflects the previous allocation total of 86,560 and last received an allocation of 1,300 Johnson & Johnson Janssen vaccines on April 3, 2021, 25,740 Pfizer-BioNTech vaccines and 15,000 Moderna vaccines on April 4, 2021.

(JIC Release No. 625)

##

Leave a Reply